Harrington discusses how the performance of milvexian in prior phase 2 trials focused on different patient populations creates the foundation for future research.
HeartBeam Announces Expansion of Its Scientific Advisory Board tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Local News: Harrington withdraws as USD 234 candidate (10/27/23) fstribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fstribune.com Daily Mail and Mail on Sunday newspapers.